{
    "hands_on_practices": [
        {
            "introduction": "Accurate diagnosis is the cornerstone of effective management in dermatology, yet overlapping clinical features can often make this challenging. This first exercise provides a practical application of Bayesian reasoning to a common diagnostic dilemma: distinguishing Polymorphous Light Eruption (PMLE) from photoallergic dermatitis. By systematically integrating clinical findings using likelihood ratios, you will practice quantifying diagnostic certainty, a core skill in modern evidence-based medicine that moves beyond intuition to structured, probabilistic assessment .",
            "id": "4481994",
            "problem": "A $32$-year-old woman presents in early spring with intensely pruritic papules and papulovesicles on the extensor forearms and V of the chest, with sparing under the watchband and under her hat brim. The eruption began approximately $24$ hours after a weekend hike with several hours of sun exposure. She reports no new topical products, sunscreens, or fragrances in the last $4$ weeks and has used the same broad-spectrum sunscreen brand for $2$ years. She notes that similar episodes have occurred in prior springs and that the lesions usually resolve spontaneously within about $7$ days without scarring if she avoids further sun exposure. On examination, there is a polymorphic morphology with coexisting erythematous papules, papulovesicles, and small plaques in a photodistributed pattern; there are no systemic symptoms. You are considering polymorphous light eruption (PMLE) versus photoallergic dermatitis.\n\nUse the following evidence-based assumptions to integrate the clinical features quantitatively. Among adults presenting with first-spring photodistributed pruritic eruptions in a general dermatology clinic without systemic symptoms, the pretest (prior) odds of polymorphous light eruption to photoallergic dermatitis are $2:1$. Assume conditional independence of the following features and the indicated approximate likelihood ratios in favor of polymorphous light eruption over photoallergic dermatitis:\n- Absence of a new topical photoallergen within $4$ weeks: likelihood ratio $= 3.0$.\n- Onset approximately $24$ hours after ultraviolet exposure: likelihood ratio $= 1.0$.\n- Polymorphic morphology (coexistence of papules, papulovesicles, and plaques): likelihood ratio $= 2.5$.\n- Spontaneous resolution within $10$ days after sun avoidance: likelihood ratio $= 2.0$.\n\nBased on these data and starting from first principles of probabilistic diagnostic reasoning, which of the following best approximates the posterior probability that the diagnosis is polymorphous light eruption for this patient?\n\nA. Approximately $97\\%$, strongly favoring polymorphous light eruption over photoallergic dermatitis\n\nB. Approximately $75\\%$, moderately favoring polymorphous light eruption over photoallergic dermatitis\n\nC. Approximately $50\\%$, equivocal between polymorphous light eruption and photoallergic dermatitis\n\nD. Approximately $20\\%$, favoring photoallergic dermatitis over polymorphous light eruption",
            "solution": "The problem statement is first subjected to validation.\n\n**Step 1: Extract Givens**\n- Patient history: A $32$-year-old woman with a history of recurrent spring-time pruritic eruptions on sun-exposed areas.\n- Current episode: Onset of pruritic papules, papulovesicles, and small plaques on the forearms and chest approximately $24$ hours after sun exposure. There is sparing of skin under a watchband and hat.\n- Relevant negatives: No new topical products, sunscreens, or fragrances in the last $4$ weeks.\n- Resolution: Past episodes resolved spontaneously in about $7$ days with sun avoidance.\n- Differential diagnosis: Polymorphous light eruption (PMLE) versus photoallergic dermatitis.\n- Prior odds (pretest odds) of PMLE to photoallergic dermatitis: $2:1$.\n- Conditional Likelihood Ratios (LR) in favor of PMLE over photoallergic dermatitis:\n    - $LR_1$ (Absence of a new topical photoallergen within $4$ weeks) $= 3.0$.\n    - $LR_2$ (Onset approximately $24$ hours after ultraviolet exposure) $= 1.0$.\n    - $LR_3$ (Polymorphic morphology) $= 2.5$.\n    - $LR_4$ (Spontaneous resolution within $10$ days after sun avoidance) $= 2.0$. The patient's history of resolution in \"about $7$ days\" is consistent with this finding.\n- Assumption: The clinical features are conditionally independent.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is a well-structured exercise in Bayesian diagnostic reasoning, a cornerstone of evidence-based medicine.\n- **Scientifically Grounded:** The problem is based on established principles of probability theory (Bayes' theorem) applied to a realistic clinical scenario in dermatology. The differential diagnosis, clinical features, and use of likelihood ratios to quantify the weight of evidence are standard in modern medical diagnostics.\n- **Well-Posed:** The problem provides all necessary quantitative data (prior odds and a complete set of likelihood ratios for the presented findings) and a key assumption (conditional independence) required to compute a unique posterior probability. The question is unambiguous.\n- **Objective:** The problem is stated in objective, clinical language. The quantitative values, though given as approximations, are precise enough for a calculation.\n\n**Step 3: Verdict and Action**\nThe problem statement is valid. It is a scientifically sound, well-posed, and objective application of probabilistic reasoning. I will proceed with the derivation of the solution.\n\n**Derivation of Posterior Probability**\nThe solution requires the application of Bayes' theorem in its odds-likelihood form. The formula states that the posterior odds of a hypothesis are equal to the prior odds multiplied by the likelihood ratio of the evidence.\n\n$$ \\text{Posterior Odds} = \\text{Prior Odds} \\times \\text{Likelihood Ratio} $$\n\nLet $H$ be the hypothesis that the patient has polymorphous light eruption (PMLE). The alternative hypothesis, $\\neg H$, is that the patient has photoallergic dermatitis (PAD).\n\nThe prior odds are given as $2:1$ in favor of PMLE.\n$$ \\text{Prior Odds}(H) = \\frac{P(H)}{P(\\neg H)} = \\frac{2}{1} = 2 $$\n\nThe problem provides four pieces of evidence ($E_1, E_2, E_3, E_4$) and their corresponding likelihood ratios ($LR_1, LR_2, LR_3, LR_4$). Since the features are assumed to be conditionally independent, the total likelihood ratio for the combined evidence is the product of the individual likelihood ratios.\n\n$$ LR_{\\text{total}} = LR(E_1, E_2, E_3, E_4|H) = LR(E_1|H) \\times LR(E_2|H) \\times LR(E_3|H) \\times LR(E_4|H) $$\nPlugging in the given values:\n$$ LR_{\\text{total}} = 3.0 \\times 1.0 \\times 2.5 \\times 2.0 $$\n$$ LR_{\\text{total}} = 3.0 \\times 5.0 $$\n$$ LR_{\\text{total}} = 15.0 $$\n\nNow, we calculate the posterior odds of PMLE.\n$$ \\text{Posterior Odds}(H) = \\text{Prior Odds}(H) \\times LR_{\\text{total}} $$\n$$ \\text{Posterior Odds}(H) = 2 \\times 15.0 = 30 $$\nThe posterior odds are $30:1$ in favor of PMLE.\n\nFinally, we convert these posterior odds into a posterior probability. The relationship between probability $P$ and odds $O$ is given by the formula $P = O / (1 + O)$.\n\n$$ P(H | \\text{Evidence}) = \\frac{\\text{Posterior Odds}(H)}{1 + \\text{Posterior Odds}(H)} $$\n$$ P(H | \\text{Evidence}) = \\frac{30}{1 + 30} = \\frac{30}{31} $$\n\nTo express this as a percentage, we perform the division:\n$$ P(H | \\text{Evidence}) \\approx 0.96774... $$\n$$ P(H | \\text{Evidence}) \\approx 96.77\\% $$\nThis value is best approximated as $97\\%$.\n\n**Evaluation of Options**\n\n*   **A. Approximately $97\\%$, strongly favoring polymorphous light eruption over photoallergic dermatitis**\n    Our calculated posterior probability is approximately $96.77\\%$, which rounds to $97\\%$. A probability of this magnitude indicates that the diagnosis of PMLE is very likely, thus \"strongly favoring\" it. This option is consistent with our derivation.\n    **Verdict: Correct**\n\n*   **B. Approximately $75\\%$, moderately favoring polymorphous light eruption over photoallergic dermatitis**\n    A probability of $75\\%$ corresponds to posterior odds of $P/(1-P) = 0.75 / (1-0.75) = 3:1$. Our calculated posterior odds are $30:1$. This option is numerically incorrect.\n    **Verdict: Incorrect**\n\n*   **C. Approximately $50\\%$, equivocal between polymorphous light eruption and photoallergic dermatitis**\n    A probability of $50\\%$ corresponds to posterior odds of $1:1$. This implies that both diagnoses are equally likely, which contradicts our calculated odds of $30:1$.\n    **Verdict: Incorrect**\n\n*   **D. Approximately $20\\%$, favoring photoallergic dermatitis over polymorphous light eruption**\n    A probability of $20\\%$ for PMLE would mean the diagnosis is unlikely, with odds of $0.20 / (1-0.20) = 0.25$, or $1:4$. This is the opposite of our finding, which strongly favors PMLE.\n    **Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Once a diagnosis of PMLE is established, patient counseling on prevention becomes paramount, with effective photoprotection being a primary strategy. This practice translates the abstract ratings on a sunscreen label into a tangible, patient-specific context. You will calculate a 'hazard quotient' to quantitatively assess whether a given sunscreen provides sufficient protection for a patient with a known UVA sensitivity threshold, thereby connecting the principles of photobiology directly to practical clinical advice .",
            "id": "4481979",
            "problem": "A patient with polymorphous light eruption (PMLE) has undergone standardized photoprovocation testing that established an individual single-exposure threshold for eliciting papular PMLE under pure ultraviolet A (UVA) irradiation of $D_{\\mathrm{th}} = 3.0\\,\\mathrm{J/cm^2}$. The patient plans a midday outdoor activity during which the incident UVA energy dose at the skin surface in the absence of photoprotection is estimated to be $D_{\\mathrm{inc}} = 10\\,\\mathrm{J/cm^2}$. The patient will use a broad-spectrum sunscreen labeled Sun Protection Factor (SPF) $50$ and a UVA protection factor measured by Persistent Pigment Darkening (PPD) of $20$. \n\nUse the following foundational definitions:\n- Sun Protection Factor (SPF) is the ratio of the ultraviolet B (UVB) energy causing a defined minimal erythema endpoint on protected skin to that on unprotected skin under the same conditions.\n- Persistent Pigment Darkening (PPD) UVA protection factor is the ratio of the UVA energy causing a defined pigment-darkening endpoint on protected skin to the dose required on unprotected skin under the same conditions.\n\nAssume the sunscreen behaves as a spectrally neutral attenuator across the UVA band for the PMLE-relevant action spectrum and that endpoint ratios generalize to linear energy attenuation under subthreshold conditions. Define the dimensionless hazard quotient $HQ$ for PMLE under this single exposure as the ratio of the residual transmitted UVA energy dose to the individual threshold $D_{\\mathrm{th}}$.\n\nCompute $HQ$ for the scenario above and use this to assess sufficiency for PMLE prevention under a single exposure, where an $HQ$ strictly less than $1$ indicates sufficiency. Report only the numerical value of $HQ$, rounded to three significant figures. No units are required for the final reported value; all intermediate physical quantities are to be expressed in $\\mathrm{J/cm^2}$ where relevant.",
            "solution": "The problem requires the calculation of a dimensionless hazard quotient, $HQ$, to assess the sufficiency of a sunscreen for preventing a polymorphous light eruption (PMLE) flare in a susceptible individual under a specific ultraviolet A (UVA) exposure scenario.\n\nThe problem is first validated to be scientifically grounded, well-posed, and objective. It uses standard definitions from photobiology and dermatology (SPF, PPD, dose-threshold), presents a clear and solvable structure, and provides realistic, self-consistent numerical values. No invalidating flaws are identified.\n\nThe calculation proceeds based on the provided definitions and data.\nThe hazard quotient, $HQ$, is defined as:\n$$\nHQ = \\frac{D_{\\mathrm{trans}}}{D_{\\mathrm{th}}}\n$$\nwhere $D_{\\mathrm{trans}}$ is the residual transmitted UVA energy dose reaching the skin, and $D_{\\mathrm{th}}$ is the individual's threshold dose for eliciting PMLE.\n\nThe given parameters are:\nIndividual UVA threshold dose for PMLE: $D_{\\mathrm{th}} = 3.0\\,\\mathrm{J/cm^2}$.\nIncident UVA energy dose without protection: $D_{\\mathrm{inc}} = 10\\,\\mathrm{J/cm^2}$.\nSunscreen UVA protection factor (PPD): $\\mathrm{PPD} = 20$.\nSunscreen Sun Protection Factor (SPF): $\\mathrm{SPF} = 50$.\n\nThe phenomenon in question, PMLE, is specified to be elicited by UVA irradiation. The Sun Protection Factor (SPF) is a metric primarily for protection against ultraviolet B (UVB) radiation, which causes erythema. The Persistent Pigment Darkening (PPD) factor is the specific metric for protection against UVA radiation. Therefore, for this problem, the PPD value is the relevant parameter for calculating UVA attenuation, and the SPF value is extraneous information.\n\nThe PPD factor is defined as the ratio of the UVA dose required to cause an effect on protected skin to the dose required on unprotected skin. Based on the assumption that this ratio generalizes to describe linear energy attenuation, the fraction of incident UVA radiation transmitted through the sunscreen is the reciprocal of the PPD factor. Let this transmittance be $T_{UVA}$.\n$$\nT_{UVA} = \\frac{1}{\\mathrm{PPD}}\n$$\nThe residual transmitted UVA dose, $D_{\\mathrm{trans}}$, is the product of the incident UVA dose, $D_{\\mathrm{inc}}$, and the transmittance, $T_{UVA}$.\n$$\nD_{\\mathrm{trans}} = D_{\\mathrm{inc}} \\times T_{UVA} = \\frac{D_{\\mathrm{inc}}}{\\mathrm{PPD}}\n$$\nSubstituting the given numerical values:\n$$\nD_{\\mathrm{trans}} = \\frac{10\\,\\mathrm{J/cm^2}}{20} = 0.5\\,\\mathrm{J/cm^2}\n$$\nNow, the hazard quotient, $HQ$, can be calculated using its definition:\n$$\nHQ = \\frac{D_{\\mathrm{trans}}}{D_{\\mathrm{th}}} = \\frac{0.5\\,\\mathrm{J/cm^2}}{3.0\\,\\mathrm{J/cm^2}}\n$$\nThe units of energy dose ($\\mathrm{J/cm^2}$) cancel, yielding a dimensionless quotient as required.\n$$\nHQ = \\frac{0.5}{3.0} = \\frac{1}{6}\n$$\nConverting this fraction to a decimal gives:\n$$\nHQ = 0.1666...\n$$\nThe problem requires the final numerical value to be rounded to three significant figures.\n$$\nHQ \\approx 0.167\n$$\nAccording to the problem's criterion, since $HQ = 0.167  1$, the photoprotection provided by the sunscreen is sufficient to prevent a PMLE flare under this single-exposure condition. The final answer is the numerical value of $HQ$.",
            "answer": "$$\\boxed{0.167}$$"
        },
        {
            "introduction": "For patients with severe or lifestyle-limiting PMLE, proactive treatment with photohardening can be a transformative intervention. This advanced practice simulates the process of designing a personalized, data-driven phototherapy protocol. You will use a patient's initial response data to estimate their unique flare threshold and then develop a safe, graded re-exposure schedule, providing a hands-on experience in the sophisticated modeling required for risk-managed therapeutic planning .",
            "id": "4481939",
            "problem": "A patient with polymorphous light eruption (PMLE) is being prepared for controlled photohardening using ultraviolet A1 (UVA1) phototherapy. Assume a constant-beam phototherapy booth with irradiance $I = 0.04 \\text{ W/cm}^2$ that does not vary across sessions. The physical dose $D$ delivered in a session of duration $t$ seconds is defined by the fundamental photobiologic relation $D = I t$, where $D$ is in $\\text{J/cm}^2$.\n\nFrom the patientâ€™s recent exposures (at identical irradiance), the following binary outcomes were recorded within $48$ hours post-exposure: a session of $t_A = 480$ seconds produced no flare, and a later session of $t_B = 840$ seconds produced a mild PMLE flare. Let the probability of a flare for a single session of dose $D$ be modeled by a logistic risk function $p(D) = \\left(1 + \\exp\\left[-k(D - \\theta)\\right]\\right)^{-1}$, where $k$ is a known slope parameter and $\\theta$ is the patient-specific flare threshold dose (the dose at which $p(D) = 0.5$). Use $k = 0.25 (\\text{J/cm}^2)^{-1}$.\n\n1. Using only the two binary outcomes above and starting from the definition of the likelihood for independent Bernoulli trials, derive the maximum likelihood estimate for the threshold $\\theta$ under this one-parameter logistic model.\n\n2. To minimize risk while initiating hardening, the first re-exposure session should be chosen so that the modeled flare probability is $p_{\\max} = 0.10$. Using your estimate of $\\theta$ and the model above, determine the corresponding safe initial dose $D_1$, then convert it to the initial session duration $t_1$ in minutes using $D_1 = I t_1$.\n\n3. For subsequent graded re-exposures, suppose hardening increases tolerance according to a patient-specific empirical relation $\\theta_{n+1} = \\theta_n + \\alpha D_n$ after session $n$ if no flare occurs, with $\\alpha = 0.05$ (unitless) and $\\theta_1 = \\theta$. Consider a multiplicative schedule $D_{n+1} = \\rho D_n$ with constant factor $\\rho > 1$, under fixed irradiance $I$. Derive, in closed form, the condition on $\\rho$ that guarantees $p(D_{n+1}) \\le p_{\\max}$ for all $n \\ge 1$ given the update rule for $\\theta_n$. You do not need to report $\\rho$ numerically.\n\nReport only the computed initial session duration $t_1$ in minutes as your final answer. Round your answer to three significant figures and express it in minutes (do not include units in the final boxed value).",
            "solution": "The problem statement has been validated and is deemed scientifically sound, well-posed, and objective. It contains sufficient information for a complete solution.\n\nThe problem is addressed in three parts as specified.\n\nFirst, we determine the maximum likelihood estimate (MLE) for the patient-specific flare threshold, $\\theta$.\nThe given constant irradiance is $I = 0.04~\\text{W/cm}^2$. The dose $D$ in J/cm$^2$ is related to exposure time $t$ in seconds by $D = I \\, t$.\n\nThe two clinical observations are:\n1.  Session A: Duration $t_A = 480~\\text{s}$, outcome $y_A = 0$ (no flare). The corresponding dose is $D_A = I \\cdot t_A = 0.04~\\text{W/cm}^2 \\times 480~\\text{s} = 19.2~\\text{J/cm}^2$.\n2.  Session B: Duration $t_B = 840~\\text{s}$, outcome $y_B = 1$ (flare). The corresponding dose is $D_B = I \\cdot t_B = 0.04~\\text{W/cm}^2 \\times 840~\\text{s} = 33.6~\\text{J/cm}^2$.\n\nThe probability of a flare for a dose $D$ is given by the logistic function:\n$$p(D) = \\left(1 + \\exp[-k(D - \\theta)]\\right)^{-1}$$\nThe probability of no flare is therefore:\n$$1 - p(D) = 1 - \\frac{1}{1 + \\exp[-k(D - \\theta)]} = \\frac{\\exp[-k(D - \\theta)]}{1 + \\exp[-k(D - \\theta)]} = \\left(1 + \\exp[k(D - \\theta)]\\right)^{-1}$$\n\nThe outcomes are independent Bernoulli trials. The likelihood function $L(\\theta)$ is the product of the probabilities of the observed outcomes:\n$$L(\\theta) = P(y_A=0 | D_A, \\theta) \\cdot P(y_B=1 | D_B, \\theta) = (1 - p(D_A)) \\cdot p(D_B)$$\n$$L(\\theta) = \\left(1 + \\exp[k(D_A - \\theta)]\\right)^{-1} \\cdot \\left(1 + \\exp[-k(D_B - \\theta)]\\right)^{-1}$$\n\nTo find the MLE, we maximize the log-likelihood function, $\\ell(\\theta) = \\ln(L(\\theta))$:\n$$\\ell(\\theta) = -\\ln\\left(1 + \\exp[k(D_A - \\theta)]\\right) - \\ln\\left(1 + \\exp[-k(D_B - \\theta)]\\right)$$\nWe find the maximum by taking the derivative with respect to $\\theta$ and setting it to zero:\n$$\\frac{d\\ell}{d\\theta} = -\\frac{\\exp[k(D_A - \\theta)] \\cdot (-k)}{1 + \\exp[k(D_A - \\theta)]} - \\frac{\\exp[-k(D_B - \\theta)] \\cdot k}{1 + \\exp[-k(D_B - \\theta)]} = 0$$\n$$\\frac{k \\exp[k(D_A - \\theta)]}{1 + \\exp[k(D_A - \\theta)]} = \\frac{k \\exp[-k(D_B - \\theta)]}{1 + \\exp[-k(D_B - \\theta)]}$$\nSince $k \\neq 0$, we can divide by $k$ and rearrange:\n$$\\frac{\\exp[k(D_A - \\theta)]}{1 + \\exp[k(D_A - \\theta)]} = \\frac{\\exp[-k(D_B - \\theta)]}{1 + \\exp[-k(D_B - \\theta)]}$$\nLet $u = \\exp[k(D_A - \\theta)]$ and $v = \\exp[-k(D_B - \\theta)]$. The equation is $\\frac{u}{1+u} = \\frac{v}{1+v}$, which simplifies to $u=v$.\n$$\\exp[k(D_A - \\theta)] = \\exp[-k(D_B - \\theta)]$$\nTaking the natural logarithm of both sides:\n$$k(D_A - \\theta) = -k(D_B - \\theta)$$\n$$D_A - \\theta = -D_B + \\theta$$\n$$2\\theta = D_A + D_B$$\nThe maximum likelihood estimate $\\hat{\\theta}$ is the arithmetic mean of the two doses:\n$$\\hat{\\theta} = \\frac{D_A + D_B}{2} = \\frac{19.2 + 33.6}{2} = \\frac{52.8}{2} = 26.4~\\text{J/cm}^2$$\n\nSecond, we calculate the safe initial dose $D_1$ and the corresponding session duration $t_1$.\nThe target maximum risk is $p_{\\max} = 0.10$. We set $p(D_1) = 0.10$ using our estimated threshold $\\hat{\\theta}$:\n$$0.10 = \\left(1 + \\exp[-k(D_1 - \\hat{\\theta})]\\right)^{-1}$$\n$$1 + \\exp[-k(D_1 - \\hat{\\theta})] = \\frac{1}{0.10} = 10$$\n$$\\exp[-k(D_1 - \\hat{\\theta})] = 9$$\nTaking the natural logarithm:\n$$-k(D_1 - \\hat{\\theta}) = \\ln(9)$$\n$$D_1 = \\hat{\\theta} - \\frac{\\ln(9)}{k}$$\nSubstituting the known values $\\hat{\\theta} = 26.4~\\text{J/cm}^2$ and $k = 0.25~(\\text{J/cm}^2)^{-1}$:\n$$D_1 = 26.4 - \\frac{\\ln(9)}{0.25} = 26.4 - 4\\ln(9) \\approx 26.4 - 4(2.1972) \\approx 17.6111~\\text{J/cm}^2$$\nTo find the initial session duration $t_1$, we use the relation $D_1 = I \\, t_1$, where $t_1$ is in seconds:\n$$t_1 = \\frac{D_1}{I} = \\frac{17.6111~\\text{J/cm}^2}{0.04~\\text{W/cm}^2} \\approx 440.2775~\\text{s}$$\nThe question requests the duration in minutes:\n$$t_1~(\\text{min}) = \\frac{440.2775}{60} \\approx 7.33796~\\text{min}$$\nRounding to three significant figures, we get $7.34$~minutes.\n\nThird, we derive the condition on the multiplicative factor $\\rho$.\nThe dose schedule is $D_{n+1} = \\rho D_n$ for $n \\ge 1$ (starting from $D_1$), and the threshold for session $n+1$ is $\\theta_{n+1} = \\theta_n + \\alpha D_n$. The initial threshold is $\\theta_1 = \\hat{\\theta}$.\nThe condition is that the flare probability for any subsequent session does not exceed the initial maximum probability $p_{\\max}$:\n$$p(D_{n+1}) \\le p_{\\max}$$\nThis must hold for all $n \\ge 1$. The calculation uses the threshold $\\theta_{n+1}$ relevant for dose $D_{n+1}$.\n$$ \\left(1 + \\exp[-k(D_{n+1} - \\theta_{n+1})]\\right)^{-1} \\le p_{\\max} $$\nBy construction, $p_{\\max} = \\left(1 + \\exp[-k(D_1 - \\theta_1)]\\right)^{-1}$. The inequality is equivalent to:\n$$-k(D_{n+1} - \\theta_{n+1}) \\ge -k(D_1 - \\theta_1)$$\nSince $-k  0$, we must reverse the inequality sign:\n$$D_{n+1} - \\theta_{n+1} \\le D_1 - \\theta_1$$\nLet $A_n = D_n - \\theta_n$. The condition is $A_{n+1} \\le A_1$ for all $n \\ge 1$.\nWe find a recurrence relation for $A_n$:\n$$A_{n+1} = D_{n+1} - \\theta_{n+1} = (\\rho D_n) - (\\theta_n + \\alpha D_n) = (\\rho - \\alpha)D_n - \\theta_n$$\nSubstitute $\\theta_n = D_n - A_n$:\n$$A_{n+1} = (\\rho - \\alpha)D_n - (D_n - A_n) = (\\rho - \\alpha - 1)D_n + A_n$$\nFor the condition $A_{n+1} \\le A_1$ to hold for all $n \\ge 1$, we first check $n=1$:\n$$A_2 = A_1 + (\\rho - \\alpha - 1)D_1$$\nFor $A_2 \\le A_1$, we need $(\\rho - \\alpha - 1)D_1 \\le 0$. Since $D_1 > 0$, this implies $\\rho - \\alpha - 1 \\le 0$.\nIf this holds, then $A_2 \\le A_1$. Now consider $A_3$:\n$$A_3 = A_2 + (\\rho - \\alpha - 1)D_2$$\nSince $D_2 = \\rho D_1 > 0$ and $\\rho - \\alpha - 1 \\le 0$, the second term is non-positive. Thus $A_3 \\le A_2$.\nBy induction, if $\\rho - \\alpha - 1 \\le 0$, then $A_{n+1} = A_n + (\\rho - \\alpha - 1)D_n \\le A_n$ for all $n \\ge 1$.\nThis forms a non-increasing sequence $A_1 \\ge A_2 \\ge A_3 \\ge \\dots$. Therefore, the condition $A_{n+1} \\le A_1$ is satisfied for all $n \\ge 1$ if and only if it is satisfied for $n=1$.\nThe required closed-form condition is:\n$$\\rho - \\alpha - 1 \\le 0 \\implies \\rho \\le 1 + \\alpha$$\nCombined with the given $\\rho > 1$, the condition on $\\rho$ is $1  \\rho \\le 1+\\alpha$.\n\nThe final answer required is the numerical value for $t_1$.\n$t_1 \\approx 7.34~\\text{min}$.",
            "answer": "$$\\boxed{7.34}$$"
        }
    ]
}